Processing

Please wait...

Settings

Settings

1. WO2020006606 - A PHARMACEUTICAL COMPOSITION AND METHOD OF USE OF SAME

Publication Number WO/2020/006606
Publication Date 09.01.2020
International Application No. PCT/AU2019/050710
International Filing Date 05.07.2019
IPC
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
70
Carbohydrates; Sugars; Derivatives thereof
7088
Compounds having three or more nucleosides or nucleotides
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
55
having seven-membered rings, e.g. azelastine, pentylenetetrazole
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
495
having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine
4985
Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
495
having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine
505
Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
519
ortho- or peri-condensed with heterocyclic rings
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
15
Drugs for genital or sexual disorders; Contraceptives
A61K 31/7088 (2006.01)
A61K 31/55 (2006.01)
A61K 31/4985 (2006.01)
A61K 31/519 (2006.01)
A61P 15/00 (2006.01)
CPC
A61K 31/138
A61K 31/4525
A61K 31/4985
A61K 31/506
A61K 31/519
A61K 31/53
Applicants
  • HELIUM 3 RESOURCES PTY LTD [AU/AU]; Brisbane, Queensland 4000, AU
Inventors
  • PALMER, Ray; AU
Agents
  • MARTIN IP PTY LTD; Brisbane, Queensland 4000, AU
  • MARTIN, Todd; AU
Priority Data
201890244405.07.2018AU
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) A PHARMACEUTICAL COMPOSITION AND METHOD OF USE OF SAME
(FR) COMPOSITION PHARMACEUTIQUE ET UTILISATION CORRESPONDANTE
Abstract
(EN)
The present disclosure relates to a pharmaceutical composition in a pharmaceutically acceptable vehicle. The pharmaceutical composition includes a physiologically effective, non-priapismic, dose of a penile-erection-inducing agent or a pharmaceutically acceptable addition salt thereof and a physiologically effective dose of an orgasm-delaying agent or a pharmaceutically acceptable addition salt thereof. The disclosed pharmaceutical composition may be useful in the treatment of erectile dysfunction and premature ejaculation.
(FR)
La présente invention concerne une composition pharmaceutique dans un véhicule pharmaceutiquement acceptable. La composition pharmaceutique comprend une dose physiologiquement efficace, sans risque de priapisme, d'un agent induisant l'érection pénienne ou d'un sel d'addition pharmaceutiquement acceptable correspondant, et une dose physiologiquement efficace d'un agent de retardement d'orgasme ou d'un sel d'addition pharmaceutiquement acceptable correspondant. La composition pharmaceutique de l'invention peut être utilisable dans le traitement de troubles de l'érection et de l'éjaculation précoce.
Latest bibliographic data on file with the International Bureau